Diane Kamen, MD
Enriched profileProfessor, Division of Rheumatology and Immunology · Medical University of South Carolina (MUSC)
Diane Kamen is Professor, Division of Rheumatology and Immunology at Medical University of South Carolina (MUSC). OpenAlex indexes 337 publications with 28,978 citations (h-index 70); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Diane L. Kamen, MD, is Professor, Division of Rheumatology and Immunology at Medical University of South Carolina (MUSC). The public record shows 337 publications with 28,978 citations (h-index 70), centered on Lupus (SLE). It also documents an investigator role on 6 registered clinical trials, industry payments reported by 7 companies, 8 NIH-funded awards (2004–2026).
- Most recent indexed publication: 2026 · Journal of racial and ethnic health disparities
- Top research focus: Lupus (SLE)
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- VIBRANT: VIB4920 for Active Lupus Nephritis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
Sponsor: Medical University of South Carolina
- Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
Sponsor: Medical University of South Carolina
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
64.9%RANK Ligand Inhibitor64.2%Denosumab100%Part B, office-administered≥16 patientsNonsteroidal Anti-inflammatory Drug0.7%Diclofenac Sodium100%Part D<11 patientsCancer & immunology
13.6%TNF inhibitor4.8%Humira Pen40%Humira(Cf) Pen36%Enbrel24%Part D<11 patientsFolate Analog Metabolic Inhibitor4.5%Methotrexate100%Part D≥19 patientsAntiparasitic
13.4%Antimalarial13.4%Hydroxychloroquine Sulfate94%Plaquenil6%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
8 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)
Medical University of South Carolina
FY2026$1,278,903U01AI184159 - A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)
Medical University of South Carolina
FY2025$1,459,720U01AI184159 - A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)
Medical University of South Carolina
FY2024$1,225,013U01AI184159
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Factors Influencing Participation in Precision Health Research Among Diverse Individuals in South Carolina.
Journal of racial and ethnic health disparities
Article2026 - A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis.
The Journal of experimental medicine
Article2025 - Towards a minimal core dataset for systemic lupus erythematosus studies.
Lupus science & medicine
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/diane-kamen-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
profiles.musc.edu/diane.kamen
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.musc.edu ↗ - ResearchGate
researchgate.net/profile/Diane-Kamen
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/MUSChealth/videos/lupus-live-qa/569832790653566
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
lupus.org/leadership/diane-kamen-md-mscr
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Spotify
creators.spotify.com/pod/profile/lupus-org/episodes/About-The-Expert-Series-eauc7a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →creators.spotify.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
- B.A./B.S.
Northwestern University (undergraduate)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗ - Board Certified
Internal Medicine and Rheumatology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com ↗
Editorial & leadership roles
journal and society appointments- Director
Lupus Clinical Trials Consortium, MUSC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Chair
Southern Section, American Federation for Medical Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Member
Systemic Lupus International Collaborating Clinics (SLICC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →musc.edu ↗
- NIH K23 Award
role of vitamin D in lupus
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - NIH R21 Award
environmental triggers of autoimmunity
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Lupus Clinical Trials Consortium / Clinical director for the lupus clinical trials consortium at MUSC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Member
Lupus Clinical Investigator Network (LuCIN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.musc.edu ↗
Media & interviews
press, podcasts and appearances- Guest
"The Expert Series" podcast (Lupus Foundation of America), 2021 lupus treatment research updates episode
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Interviewed alongside Sandra Raymond on UNVEIL survey findings
Luck Fupus podcast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.soundcloud.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gary Gilkeson, MD
Medical University of South Carolina (MUSC)
Gerard Silvestri, MD
Medical University of South Carolina (MUSC)
Patrick Flume, MD
Medical University of South Carolina (MUSC)